Vaccinex Financial Statements From 2010 to 2024
VCNX Stock | USD 7.45 0.10 1.32% |
Gross Profit -13.7 M | Market Capitalization 8.8 M | Enterprise Value Revenue 14.4969 | Revenue 795 K | Earnings Share (83.86) |
Check Vaccinex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaccinex main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 19.7 K or Depreciation And Amortization of 282.2 K, as well as many exotic indicators such as Price To Sales Ratio of 2.2 K, Dividend Yield of 0.0 or Operating Cycle of 444. Vaccinex financial statements analysis is a perfect complement when working with Vaccinex Valuation or Volatility modules.
Vaccinex | Select Account or Indicator |
Vaccinex Balance Sheet | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vaccinex Income Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vaccinex Cash Flow Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Vaccinex Fundamental Market Drivers
Cash And Short Term Investments | 6.4 M |
Vaccinex Upcoming Events
1st of April 2024 Upcoming Quarterly Report | View | |
31st of December 2023 Next Fiscal Quarter End | View |
About Vaccinex Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Vaccinex income statement, its balance sheet, and the statement of cash flows. Vaccinex investors use historical funamental indicators, such as Vaccinex's revenue or net income, to determine how well the company is positioned to perform in the future. Although Vaccinex investors may use each financial statement separately, they are all related. The changes in Vaccinex's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Vaccinex's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Vaccinex Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Vaccinex. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for 2024 | ||
Current Deferred Revenue | 268.2 K | 238.4 K | |
Total Revenue | 620 K | 456.9 K | |
Cost Of Revenue | 186.3 K | 215.4 K | |
Ebit Per Revenue | (228.92) | (240.36) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vaccinex in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vaccinex's short interest history, or implied volatility extrapolated from Vaccinex options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.MSFT | Microsoft | |
GOOG | Alphabet Class C | |
S | SentinelOne |
Check out the analysis of Vaccinex Correlation against competitors. For more information on how to buy Vaccinex Stock please use our How to Invest in Vaccinex guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Vaccinex Stock analysis
When running Vaccinex's price analysis, check to measure Vaccinex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaccinex is operating at the current time. Most of Vaccinex's value examination focuses on studying past and present price action to predict the probability of Vaccinex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaccinex's price. Additionally, you may evaluate how the addition of Vaccinex to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Vaccinex's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vaccinex. If investors know Vaccinex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vaccinex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (83.86) | Revenue Per Share 2.987 | Quarterly Revenue Growth (0.60) | Return On Assets (2.58) | Return On Equity (17.98) |
The market value of Vaccinex is measured differently than its book value, which is the value of Vaccinex that is recorded on the company's balance sheet. Investors also form their own opinion of Vaccinex's value that differs from its market value or its book value, called intrinsic value, which is Vaccinex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaccinex's market value can be influenced by many factors that don't directly affect Vaccinex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaccinex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vaccinex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaccinex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.